Cocaine self-administration in dopamine-transporter knockout mice

被引:422
|
作者
Rocha, BA
Fumagalli, F
Gainetdinov, RR
Jones, SR
Ator, R
Giros, B
Miller, GW
Caron, MG [1 ]
机构
[1] Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA
[3] Univ N Texas, Ctr Hlth Sci, Dept Pharmacol, Ft Worth, TX 76107 USA
关键词
D O I
10.1038/381
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The plasma membrane dopamine transporter (DAT) is responsible for clearing dopamine from the synapse. Cocaine blockade of DAT leads to increased extracellular dopamine, an effect widely considered to be the primary cause of the reinforcing and addictive properties of cocaine. In this study we tested whether these properties are limited to the dopaminergic system in mice lacking DAT. In the absence of DAT, these mice exhibit high levels of extracellular dopamine, but paradoxically still self-administer cocaine. Mapping of the sites of cocaine binding and neuronal activation suggests an involvement of serotonergic brain regions in this response. These results demonstrate that the interaction of cocaine with targets other than DAT, possibly the serotonin transporter, can initiate and sustain cocaine self-administration in these mice.
引用
收藏
页码:132 / 137
页数:6
相关论文
共 50 条
  • [1] Cocaine self-administration in dopamine-transporter knockout mice
    Beatriz A. Rocha
    Fabio Fumagalli
    Raul R. Gainetdinov
    Sara R. Jones
    Robert Ator
    Bruno Giros
    Gary W. Miller
    Marc G. Caron
    Nature Neuroscience, 1998, 1 : 132 - 137
  • [2] Erratum: Cocaine self-administration in dopamine-transporter knockout mice
    Beatriz Rocha
    Fabio Fumagalli
    Raul Gainetdinov
    Sara Jones
    Robert Ator
    Bruno Giros
    Gary Miller
    Marc Caron
    Nature Neuroscience, 1998, 1 : 330 - 330
  • [3] Cocaine self-administration in dopamine-transporter knockout mice (vol 1, pg 132, 1998)
    Rocha, BA
    Fumagalli, F
    Gainetdinov, RR
    Jones, SR
    Ator, R
    Giros, B
    Miller, GW
    Caron, MG
    NATURE NEUROSCIENCE, 1998, 1 (04) : 330 - 330
  • [4] Lack of Cocaine Self-Administration in Mice Expressing a Cocaine-Insensitive Dopamine Transporter
    Thomsen, Morgane
    Han, Dawn D.
    Gu, Howard H.
    Caine, S. Barak
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (01): : 204 - 211
  • [5] Cocaine Self-Administration in Dopamine D3 Receptor Knockout Mice
    Caine, S. Barak
    Thomsen, Morgane
    Barrett, Andrew C.
    Collins, Gregory T.
    Grundt, Peter
    Newman, Amy Hauck
    Butler, Paul
    Xu, Ming
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2012, 20 (05) : 352 - 363
  • [6] Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice
    Spielewoy, C
    Roubert, C
    Hamon, M
    Nosten-Bertrand, M
    Betancur, C
    Giros, B
    BEHAVIOURAL PHARMACOLOGY, 2000, 11 (3-4): : 279 - 290
  • [7] Increased rewarding properties of morphine in dopamine-transporter knockout mice
    Spielewoy, C
    Gonon, F
    Roubert, C
    Fauchey, V
    Jaber, M
    Caron, MG
    Roques, BP
    Hamon, M
    Betancur, C
    Maldonado, R
    Giros, B
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (05) : 1827 - 1837
  • [8] Dramatically Decreased Cocaine Self-Administration in Dopamine But Not Serotonin Transporter Knock-Out Mice
    Thomsen, Morgane
    Hall, F. Scott
    Uhl, George R.
    Caine, S. Barak
    JOURNAL OF NEUROSCIENCE, 2009, 29 (04): : 1087 - 1092
  • [9] MDMA self-administration is abolished in serotonin transporter knockout mice
    Diaz, J. M. Trigo
    Renoir, T.
    Lanfumey, L.
    Hamon, M.
    Robledo, P.
    Maldonado, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S514 - S515
  • [10] Decreases in Cocaine Self-Administration with Dual Inhibition of the Dopamine Transporter and σ Receptors
    Hiranita, Takato
    Soto, Paul L.
    Kohut, Stephen J.
    Kopajtic, Theresa
    Cao, Jianjing
    Newman, Amy H.
    Tanda, Gianluigi
    Katz, Jonathan L.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02): : 662 - 677